Patents by Inventor Hiroshi Kondo

Hiroshi Kondo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20020021014
    Abstract: A shock absorbing portion is pivotally supported on a grip body and is fixed to a vehicle body steel plate. A claw portions are protruded inwardly from a first and second side surface portions of a cover for covering a bridge portion so as to be inclined toward a bottom portion at an acute angle with respect to a normal respectively, and are engaged with engagement holes of the bridge portion and are held and fixed thereto respectively, and the cover is fixed to the bridge portion such that an opening faces opposite to a vehicle compartment.
    Type: Application
    Filed: August 13, 2001
    Publication date: February 21, 2002
    Inventors: Yoshiyuki Sakuma, Takashi Hosokawa, Chiharu Totani, Hiroyuki Tajima, Hiroshi Kondo, Shigeru Yabuya
  • Patent number: 6313302
    Abstract: A compound of the following formula: and the salts thereof, wherein A is hydrogen, halo, or hydroxy; the broken line represents an optional double bond with proviso that if the broken line is a double bond, then A is absent; Ar1 is optionally substituted phenyl; Ar2 is aryl or heteroaryl selected from phenyl, napththyl, or pyridyl, the aryl or heteroaryl being optionally substituted; R1 is hydrogen, hydroxy, or C1-C4 alkyl; and R2 and R3 are independently selected from optionally substituted C1-C7 alkyl, C3-C6 cycloalkyl, C2-C6 alkenyl, C2-C6 alkynyl, or R2 and R3, together with the nitrogen atom to which they are attached, form an optionally substituted pyrrolidine. These compounds are useful as kappa agonists.
    Type: Grant
    Filed: January 26, 2001
    Date of Patent: November 6, 2001
    Assignee: Pfizer Inc.
    Inventors: Fumitaka Ito, Hiroshi Kondo
  • Patent number: 6310061
    Abstract: A compound of the following formula: and the salts thereof, wherein A is hydrogen, halo, or hydroxy; the broken line represents an optional double bond with proviso that if the broken line is a double bond, then A is absent; Ar1 is optionally substituted phenyl; Ar2 is aryl or heteroaryl selected from phenyl, napththyl, or pyridyl, the aryl or heteroaryl being optionally substituted; R1 is hydrogen, hydroxy, or C1-C4 alkyl; and R2 and R3 are independently selected from optionally substituted C1-C7 alkyl, C3-C6 cycloalkyl, C2-C6 alkenyl, C2-C6 alkynyl, or R2 and R3, together with the nitrogen atom to which they are attached, form an optionally substituted pyrrolidine, piperidine or morpholine ring. These compounds are useful as kappa agonists.
    Type: Grant
    Filed: January 26, 2001
    Date of Patent: October 30, 2001
    Assignee: Pfizer Inc.
    Inventors: Fumitaka Ito, Hiroshi Kondo
  • Patent number: 6307061
    Abstract: A compound of the following formula: and the salts thereof, wherein A is hydrogen, halo, hydroxy, or the like; the broken line represents an optional double bond with proviso that if the broken line is a double bond, then A is absent; Ar1 is optionally substituted phenyl or the like; Ar2 is aryl or heteroaryl selected from phenyl, napththyl, pyridyl, and the like, the aryl or heteroaryl being optionally substituted; R1 is hydrogen, hydroxy, C1-C4 alkyl, or the like; and R2 and R3 are independently selected from optionally substituted C1-C7 alkyl, C3-C6 cycloalkyl, C2-C6 alkenyl, C2-C6 alkynyl, and the like or R2 and R3, together with the nitrogen atom to which they are attached, form an optionally substituted pyrrolidine, piperidine or morpholine ring. These compounds are useful as kappa agonists.
    Type: Grant
    Filed: January 26, 2001
    Date of Patent: October 23, 2001
    Assignee: Pfizer Inc.
    Inventors: Fumitaka Ito, Hiroshi Kondo
  • Patent number: 6303602
    Abstract: A compound of the following formula: or a salt thereof, wherein A is hydrogen, halo, hydroxy; the broken line represents an optional double bond with proviso that if the broken line is a double bond, then A is absent; Ar1 is optionally substituted phenyl; Ar2 is aryl or heteroaryl selected from phenyl, napththyl, furanyl or thienyl, the aryl or heteroaryl being optionally substituted; R1 is hydrogen, hydroxy, or C1-C4 alkyl; and R2 and R3 are independently selected from optionally substituted C1-C7 alkyl, C3-C6 cycloalkyl, C2-C6 alkenyl, C2-C6 alkynyl, or R2 and R3, together with the nitrogen atom to which they are attached, form an optionally substituted pyrrolidine, piperidine or morpholine ring. These compounds are useful as kappa agonists.
    Type: Grant
    Filed: January 26, 2001
    Date of Patent: October 16, 2001
    Assignee: Pfizer Inc.
    Inventors: Fumitaka Ito, Hiroshi Kondo
  • Publication number: 20010023703
    Abstract: When a ground fault occurs in some solar battery string, this solar battery string may be disconnected and operation of a solar power generation system may be continued. If the open-circuit voltage of the solar battery string is high, a safety problem arises. If the open-circuit voltage is decreased, the conversion efficiency decreases. Therefore, an intermediate switch is provided midway along the solar battery string. When a ground fault occurs, this solar battery string where the ground fault has occurred is divided into substrings.
    Type: Application
    Filed: February 26, 2001
    Publication date: September 27, 2001
    Inventors: Hiroshi Kondo, Naoki Manabe, Nobuyoshi Takehara
  • Patent number: 6294557
    Abstract: A compound of the following formula: and the salts thereof, wherein A is hydrogen, halo, hydroxy, or the like; the broken line represents an optional double bond with proviso that if the broken line is a double bond, then A is absent; Ar1 is optionally substituted phenyl or the like; Ar2 is aryl or heteroaryl selected from phenyl, napththyl, pyridyl, and the like, the aryl or heteroaryl being optionally substituted; R1 is hydrogen, hydroxy, C1-C4 alkyl, or the like; and R2 and R3 are independently selected from optionally substituted C1-C7 alkyl, C3-C6 cycloalkyl, C2-C6 alkenyl, C2-C6 alkynyl, and the like or R2 and R3, together with the nitrogen atom to which they are attached, form an optionally substituted pyrrolidine, piperidine or morpholine ring. These compounds are useful as kappa agonists.
    Type: Grant
    Filed: January 26, 2001
    Date of Patent: September 25, 2001
    Assignee: Pfizer Inc.
    Inventors: Fumitaka Ito, Hiroshi Kondo
  • Patent number: 6294569
    Abstract: A compound of the following formula: and the salts thereof, wherein A is hydrogen, halo, hydroxy, or the like; the broken line represents an optional double bond with proviso that if the broken line is a double bond, then A is absent; Ar1 is optionally substituted phenyl or the like; Ar2 is aryl or heteroaryl selected from phenyl, napththyl, pyridyl, and the like, the aryl or heteroaryl being optionally substituted; R1 is hydrogen, hydroxy, C1-C4 alkyl, or the like; and R2 and R3 are independently selected from optionally substituted C1-C7 alkyl, C3-C6 cycloalkyl, C2-C6 alkenyl, C2-C6 alkynyl, and the like or R2 and R3, together with the nitrogen atom to which they are attached, form an optionally substituted pyrrolidine, piperidine or morpholine ring. These compounds are useful as kappa agonists.
    Type: Grant
    Filed: January 26, 2001
    Date of Patent: September 25, 2001
    Assignee: Pfizer Inc.
    Inventors: Fumitaka Ito, Hiroshi Kondo
  • Publication number: 20010020024
    Abstract: A compound of the following formula: 1
    Type: Application
    Filed: January 26, 2001
    Publication date: September 6, 2001
    Inventors: Fumitaka Ito, Hiroshi Kondo
  • Publication number: 20010014683
    Abstract: A compound of the following formula: 1
    Type: Application
    Filed: January 26, 2001
    Publication date: August 16, 2001
    Inventors: Fumitaka Ito, Hiroshi Kondo
  • Patent number: 6273795
    Abstract: Disclosed is a method of effectively dressing a grinding wheel of high grain concentration having a high wheel number usable for an ultrahigh precision processing. When a grinding wheel (10) is trued (i.e., formed into a predetermined shape) by using a truing tool (11), the grinding wheel (10) is dressed by feeding a coolant W in which abrasive grains (12) for dressing are dispersed into a space between the truing tool (11) and a surface (13) of the grinding wheel (10). Therefore, it is possible to easily true and dress the ultra-fine grinding wheel usable for ultra-high precision processing, without being affected by the manufacturing limit of the dressing tool, being different from the dressing method using a dressing tool.
    Type: Grant
    Filed: December 17, 1997
    Date of Patent: August 14, 2001
    Assignee: Toshiba Kikai Kabushiki Kaisha
    Inventors: Mitsuoki Hatamoto, Hiroshi Kondo, Kazunori Urushibata
  • Publication number: 20010011091
    Abstract: A compound of the following formula: 1
    Type: Application
    Filed: January 26, 2001
    Publication date: August 2, 2001
    Inventors: Fumitaka Ito, Hiroshi Kondo
  • Publication number: 20010009921
    Abstract: A compound of the following formula: 1
    Type: Application
    Filed: January 26, 2001
    Publication date: July 26, 2001
    Inventors: Fumitaka Ito, Hiroshi Kondo
  • Publication number: 20010008890
    Abstract: A compound of the following formula: 1
    Type: Application
    Filed: January 26, 2001
    Publication date: July 19, 2001
    Inventors: Fumitaka Ito, Hiroshi Kondo
  • Publication number: 20010002453
    Abstract: An electronic control apparatus for engines has a memory and a processing unit. The processing unit executes various processing routines while accessing the memory in a predetermined access speed or wait-time. The routines include a rotation interrupt routine which is initiated in synchronized relation with a rotation of an engine. The memory access speed of the processing unit is set initially to a low speed, when an ignition switch is turned on to start a power supply to the processing unit. However, it is changed to a high access speed, when a rotation speed of the engine increases and a rate of execution of the interrupt routine by the processing unit increases.
    Type: Application
    Filed: November 30, 2000
    Publication date: May 31, 2001
    Inventor: Hiroshi Kondo
  • Patent number: 6222038
    Abstract: Compounds of the formula wherein R1 is methoxy and R2 is selected from the group consisting of methyl, ethyl, isopropyl, sec-butyl and tert-butyl; and the pharmaceutically acceptable salts of such compounds. These compounds are substance P antagonists and useful in the treatment of gastrointestinal disorders, inflammatory disorders, central nervous system disorders and pain.
    Type: Grant
    Filed: January 24, 1995
    Date of Patent: April 24, 2001
    Inventors: Fumitaka Ito, Hiroshi Kondo, Masami Nakane, John Adams Lowe, III, Terry Jay Rosen, Kaoru Shimada
  • Patent number: 6201007
    Abstract: A compound of the following formula: and the salts thereof wherein A is hydrogen, halo, or hydroxy, broken line represents an optional double bond with proviso that if the broken line is a double bond, then A is absent; Ar1 is optionally substituted phenyl; Ar2 is aryl or heteroaryl selected from phenyl, napththyl, or pyridyl, the aryl or heteroaryl being optionally substituted; R1 is hydrogen, hydroxy, or C1-C4 alkyl; and R2 and R3 are independently selected from optionally substituted C1-C7 alkyl, C3-C6 cycloalkyl, C2-C6 alkenyl, C2-C6 alkynyl, or R2 and R3, together with the nitrogen atom to which they are attached, form an optionally substituted pyrrolidine. These compounds are useful as kappa agonists.
    Type: Grant
    Filed: March 12, 1999
    Date of Patent: March 13, 2001
    Assignee: Pfizer Inc.
    Inventors: Fumitaka Ito, Hiroshi Kondo
  • Patent number: 6172067
    Abstract: A compound of the formula: or a pharmaceutically acceptable salt thereof, wherein R is unsubstituted, mono-, di- or tri-substituted (C3-C11)cycloalkyl or (C3-C11)cycloalkenyl or the like, A is unsubstituted (C1-C7)alkyl or (C2-C5 )alkenyl, or unsubstituted, mono-, di- or tri-substituted aryl, or aromatic-heterocyclic or the like, Y is hydrogen, halo, amino or mercapto, or unsubstituted, mono-, di- or tri- substituted (C1-C10)alkyl-M—, (C3-C7)cycloalkyl-M—, (C2-C6)alkenyl-M—, (C1-C4)alkyl-NH-((C1-C4)alkyl)-M—, di(C1-C4)alkyl-N-((C1-C4)alkyl)-M—, aryl-M—, aromatic or non-aromatic heterocyclic-M—, aryl-(C1-C5)alkyl-M— or aromatic non-aromatic heterocyclic-(C1-C5)alkyl-M—, wherein M is a covalent bond O, S, NH or the like, or the like; Z1, Z2, Z3 and Z4 are hydrogen or the like, has ORL1-receptor agonist activity, and are useful as analgesics or the like in mammalian subjects.
    Type: Grant
    Filed: August 5, 1999
    Date of Patent: January 9, 2001
    Assignee: Pfizer Inc.
    Inventors: Fumitaka Ito, Hirohide Noguchi, Hiroshi Kondo
  • Patent number: 6169678
    Abstract: A photovoltaic power generation apparatus having a plurality of power converters, respectively connected to a plurality of solar battery arrays, for converting direct-current power generated by the solar battery arrays to alternating-current power so as to provide the alternating-current power to a commercial power system. The photovoltaic power generation apparatus is so constructed that the plurality of power converters do not simultaneously suspend operation when an abnormal state is detected, in order to prevent generation of an electrical stress or reduction of the power generation amount caused by simultaneous operation suspension of the power converters or repeated operation suspension and operation resume. When the power generation amount of each solar battery array is different, a power converter connected to the solar battery array of the smallest power generation amount is set in the first-to-suspend condition.
    Type: Grant
    Filed: January 27, 2000
    Date of Patent: January 2, 2001
    Assignee: Canon Kabushiki Kaisha
    Inventors: Hiroshi Kondo, Naoki Manabe, Nobuyoshi Takehara
  • Patent number: 6107560
    Abstract: A solar cell array used in a photovoltaic power generation apparatus for housing covers a relatively large outside area for installation, and a considerably large earth capacitance Ca exists between the solar cell array and the ground. Further, as an inverter for converting direct-current electric power generated by the solar cell array into alternating-current electric power, a transless-type inverter is used for reducing cost. Therefore, a slight leak current flows via the earth capacitance Ca, which may cause undesirable operation of an earth leakage circuit breaker inserted between the inverter and a commercial AC power system. In the photovoltaic power generation apparatus of the present invention, by designing it so that the relationship between the earth capacitance Ca[.mu.F] and leak current detection sensitivity EL[mA] of the earth leakage circuit breaker is Ca<EL/3, the undesirable operation of the earth leakage circuit breaker due to the leak current is prevented.
    Type: Grant
    Filed: May 1, 1998
    Date of Patent: August 22, 2000
    Assignee: Canon Kabushiki Kaisha
    Inventors: Nobuyoshi Takehara, Hiroshi Kondo, Seiji Kurokami